Hispanic dialysis patients face 40% higher risk of staph infection than whites, CDC says

Hispanic dialysis patients face 40% higher risk of staph infection than whites, CDC says


Hispanic dialysis patients face a 40% higher risk of developing a staph bloodstream infection compared with whites, underscoring economic and racial disparities in the U.S. health-care system, according to new data released Monday by the Centers for Disease Control and Prevention.

Adults on dialysis for kidney failure were 100 times more likely to contract staph bloodstream infections compared with the general U.S. population, the CDC said. Needles and catheters are used to connect patients to dialysis, and bacteria like staph can enter a patient’s bloodstream during the process. Staph infections are serious and sometimes deadly.

“Infections overall are thought to be the second-leading cause of death in dialysis patients — that’s all infections, not just bloodstream infections,” Dr. Shannon Novosad, head of the CDC’s dialysis safety team, told reporters during a call Monday. “They’re also one of the leading causes of hospitalizations for these patients.”

More than 800,000 people in the U.S. are living with kidney failure, 70% of whom are on dialysis, according to the CDC.

People of color, however, face an even higher risk of kidney failure, representing more than half of dialysis patients. The rate of kidney failure is four times higher among Black people and two times higher among Hispanics than white people, according to CDC data. Black people represent 33% of all patients in the U.S. on dialysis.

Black and Hispanic people on dialysis were also more likely to contract staph infections than white patients, the CDC said. The data analyzing dialysis patients from 2017 to 2020 didn’t clearly calculate the increased risk for Black patients. Hispanic patients, however, faced a 40% higher risk of staph infection than whites, according to the CDC.

More patients on dialysis with staph bloodstream infections lived in areas with higher poverty, more household crowding and lower education levels, Novosad said. About 42% of staph infections among dialysis patients occurred in areas with the highest levels of poverty, she said.

The CDC study looked at data from select counties in seven states from 2017 through 2020. The states are California, Connecticut, Georgia, Maryland, New York, Tennessee and Minnesota.

Bloodstream infections in patients on dialysis declined 40% from 2014 to 2019 due to staff and patient education on how to prevent them, according to the CDC. The use of fistulas and grafts to connect a patient’s blood circulation to the dialysis machine reduces the risk of infection compared with catheters.

“Preventing staph bloodstream infections begins by detecting chronic kidney disease in its early stages to prevent or delay the need for dialysis,” said CDC Chief Medical Officer Dr. Debra Houry.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More